【正文】 1001元以上200元。h233。利用網(wǎng)路二十四小時(shí)開放的便利性、即時(shí)性，衛(wèi)生署不妨考慮先開放在地區(qū)或區(qū)域級(jí)以上醫(yī)療院所就醫(yī)的慢性病患，經(jīng)醫(yī)師評(píng)估病況穩(wěn)定的情況下，讓患者透過認(rèn)證的合法網(wǎng)路藥局領(lǐng)藥，不但可防止病患舟車往返及等候的不便，網(wǎng)路藥局的便利性及專業(yè)認(rèn)證，也可讓醫(yī)師放心釋出處方箋，加速醫(yī)藥分業(yè)的進(jìn)展。,Following review of the application materials, verification of submitted information and licensure, and survey, a written report will be sent to the pharmacy. If the review is satisfactory, a recommendation to award accreditation is submitted to NABP’s accreditation committee. Upon accreditation approval, a VIPPS Letter of Agreement to be signed by an authorized representative or agent of the entity will be sent to the pharmacy.,Accreditation Process,55,第五十五頁，共六十四頁。,Patient Services The pharmacy must provide, on the Web site, a 24hour toll free number for patients who experience or believe they have experienced an adverse event involving their medication. The pharmacy must provide, on the Web site, the US street address of the pharmacy that dispenses prescription medications on behalf of (or through) the Web site. The pharmacy must provide, on the Web site, the US street address of the site’s corporate headquarters or primary place of business. The pharmacy must provide, on the Web site, instructions to patients describing how to submit complaints or concerns. The pharmacy must offer pharmacist medication consultation via secure means through the Web site, via telephone, or in person for walkin patients.,Program Criteria: Patient Safety and Pharmacy Practice Standards,51,第五十一頁，共六十四頁。,Prescriptions The pharmacy, in accordance with applicable state and federal laws and regulations, must assure the legitimacy and authenticity of all prescription drug orders. A legitimate and authentic prescription drug order must be based upon a valid patientprescriber relationship, which requires the following to have been established: a) The patient has a legitimate medical complaint。,Questionable professional practices: Many Internet drug outlets operate without a license or in conflict with the laws and regulations created to ensure patient safety. Furthermore, some of the medicines being sold on these Web sites may be too strong, too weak, fake, expired, stolen, diluted, or impure. Frequently, deceived patients notify us that they have not received the medicines they ordered, or that the site operators refuse to remove credit card charges. Many also complain that they are unable to contact anyone at the organization。),35,第三十五頁，共六十四頁。,(VIPPS174。,Verified Internet Pharmacy Practice Sites? (VIPPS174。 (NABP174。,第五章 網(wǎng)路購買處方藥之平安(p237。 二、所含有效成分之質(zhì)、量或強(qiáng)度，與核準(zhǔn)不符者。 二、所含有效成分之名稱，與核準(zhǔn)不符者。nɡ)，而目前網(wǎng)路商店因?qū)偬摂M空間，無 法滿足藥商營業(yè)場所之定義，因此制止在網(wǎng)路上 販?zhǔn)廴魏畏N類的藥品或醫(yī)療器材。ch233。 自九十年七月(qī yu232。,第二章 處方藥獲得(hu242。)途徑分析,第一(d236。fǎ)藥品辨識(shí)方法,指示(zhǐsh236。,第三(d236。,4,第四頁，共六十四頁。o)藥品使用方法及平安性分為： 成藥、指示藥、處方藥 藥事法 第8條 本法所稱製劑，係指以原料藥經(jīng)加工調(diào)製，製成一定劑型及劑量之藥品。 製劑分為醫(yī)師處方藥品、醫(yī)師藥師藥劑生指示藥品、成藥及固有成方製劑,2,第二頁，共六十四頁。,第二(d236。 sān)節(jié) 處方藥,限制(xi224。)用藥 藥品外盒包裝上印有 衛(wèi)生署許可的證號(hào)：「衛(wèi)署藥製字第xxxxxx號(hào)」或「衛(wèi)署藥輸字第xxxxxx號(hào)」 外盒包裝有「醫(yī)師藥師藥劑生指示藥品 」 的標(biāo)示,9,第九頁，共六十四頁。yī)節(jié) 醫(yī)院及診所之藥局 藥事法施行細(xì)則 第 3 條 本法第八條第二項(xiàng)所稱醫(yī)師處方藥品，係 指經(jīng)中央衛(wèi)生主管機(jī)關(guān)審定，在藥品許可 證上，載明須由醫(yī)師處方或限由醫(yī)師使用 者。d233。)一日起，保險(xiǎn)對(duì)象持處方箋至特約 藥局調(diào)劑，需依規(guī)定繳交藥品局部負(fù)擔(dān)金額,第三章 醫(yī)藥分業(yè),16,第十六頁，共六十四頁。ng)與看病等候的時(shí)間。 衛(wèi)生署目前未核準(zhǔn)任何網(wǎng)路藥局,第四章 網(wǎng)路販賣處方藥現(xiàn)況,20,第二十頁，共六十四頁。 三、將別人產(chǎn)品抽換或摻雜者。 三、藥品中一部或全部含有污穢或異物者。ng ān)性,第三節(jié) 禁藥 藥事法 第22條 本法所稱禁藥，係指藥品有左列各款情形之一 一、經(jīng)中央衛(wèi)生主管機(jī)關(guān)明令公告制止製造、調(diào)劑、輸 入、輸出、販賣或陳列之毒害藥品。),25,第二十五頁，共六十四頁。),28,第二十八頁，共六十四頁。),32,第三十二頁，共六十四頁。,Not Recommended Sites: These Internet drug outlets appear to be out of compliance with state and federal laws or NABP patient safety and pharmacy practice standards.,(VIPPS174。 phone lines are disconnected, no one answers, or no phone number is provided.,Buying Medicine Online,41,第四十一頁，共六十四頁。 b) A facetoface physical examination adequate to establish the legitimacy of the medical complaint has been performed by the prescribing practitioner or in the instances of telemedicine through a telemedicine practice approved by the appropriate Practitioner Board。,Professional Practices The pharmacy must attest and provide documentation to NABP that it obtains medications from US licensed wholesale drug distributors and/or US licensed or FDA registered pharmaceutical manufacturers. The pharmacy must maintain a currently registered domain name.,Program Criteria: Patient Safety and Pharmacy Practice Standards,52,第五十二頁，共六十